Literature DB >> 21052797

Lipophilicity and its relationship with passive drug permeation.

Xiangli Liu1, Bernard Testa, Alfred Fahr.   

Abstract

In this review, we first summarize the structure and properties of biological membranes and the routes of passive drug transfer through physiological barriers. Lipophilicity is then introduced in terms of the intermolecular interactions it encodes. Finally, lipophilicity indices from isotropic solvent systems and from anisotropic membrane-like systems are discussed for their capacity to predict passive drug permeation across biological membranes such as the intestinal epithelium, the blood-brain barrier (BBB) or the skin. The broad evidence presented here shows that beyond the predictive power of lipophilicity parameters, the various intermolecular forces they encode allow a mechanistic interpretation of passive drug permeation.

Mesh:

Substances:

Year:  2010        PMID: 21052797     DOI: 10.1007/s11095-010-0303-7

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  73 in total

1.  Improvement of oral peptide bioavailability: Peptidomimetics and prodrug strategies.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1997-09-15       Impact factor: 15.470

2.  Determination of the passive absorption through the rat intestine using chromatographic indices and molar volume.

Authors:  M Genty; G González; C Clere; V Desangle-Gouty; J Y Legendre
Journal:  Eur J Pharm Sci       Date:  2001-01       Impact factor: 4.384

3.  Lipophilicity Profiles of Ampholytes.

Authors:  Alessandra Pagliara; Pierre-Alain Carrupt; Giulia Caron; Patrick Gaillard; Bernard Testa
Journal:  Chem Rev       Date:  1997-12-18       Impact factor: 60.622

Review 4.  Immobilized artificial membrane HPLC in drug research.

Authors:  Agnes Taillardat-Bertschinger; Pierre-Alain Carrupt; Francesco Barbato; Bernard Testa
Journal:  J Med Chem       Date:  2003-02-27       Impact factor: 7.446

5.  Non steady-state descriptions of drug permeation through stratum corneum. I. The biphasic brick-and-mortar model.

Authors:  M Heisig; R Lieckfeldt; G Wittum; G Mazurkevich; G Lee
Journal:  Pharm Res       Date:  1996-03       Impact factor: 4.200

6.  Interactions between model membranes and lignin-related compounds studied by immobilized liposome chromatography.

Authors:  Elisabet Boija; Gunnar Johansson
Journal:  Biochim Biophys Acta       Date:  2006-04-21

7.  Drug liposome partitioning as a tool for the prediction of human passive intestinal absorption.

Authors:  K Balon; B U Riebesehl; B W Müller
Journal:  Pharm Res       Date:  1999-06       Impact factor: 4.200

8.  Can protonated beta-blockers interact with biomembranes stronger than neutral isolipophilic compounds? A chromatographic study on three different phospholipid stationary phases (IAM-HPLC).

Authors:  Francesco Barbato; Giuseppina di Martino; Lucia Grumetto; Maria Immacolata La Rotonda
Journal:  Eur J Pharm Sci       Date:  2005 Jul-Aug       Impact factor: 4.384

9.  The fluid mosaic model of the structure of cell membranes.

Authors:  S J Singer; G L Nicolson
Journal:  Science       Date:  1972-02-18       Impact factor: 47.728

10.  Azole endothelin antagonists. 3. Using delta log P as a tool to improve absorption.

Authors:  T W von Geldern; D J Hoffman; J A Kester; H N Nellans; B D Dayton; S V Calzadilla; K C Marsh; L Hernandez; W Chiou; D B Dixon; J R Wu-Wong; T J Opgenorth
Journal:  J Med Chem       Date:  1996-02-16       Impact factor: 7.446

View more
  45 in total

1.  A Family of Rhodium Complexes with Selective Toxicity toward Mismatch Repair-Deficient Cancers.

Authors:  Kelsey M Boyle; Jacqueline K Barton
Journal:  J Am Chem Soc       Date:  2018-04-17       Impact factor: 15.419

2.  Boosting antioxidants by lipophilization: a strategy to increase cell uptake and target mitochondria.

Authors:  Christelle Bayrasy; Béatrice Chabi; Mickaël Laguerre; Jérôme Lecomte; Elodie Jublanc; Pierre Villeneuve; Chantal Wrutniak-Cabello; Gérard Cabello
Journal:  Pharm Res       Date:  2013-04-19       Impact factor: 4.200

3.  Identification of peptidomimetics as novel chemical probes modulating fibroblast growth factor 14 (FGF14) and voltage-gated sodium channel 1.6 (Nav1.6) protein-protein interactions.

Authors:  Zhiqing Liu; Paul Wadsworth; Aditya K Singh; Haiying Chen; Pingyuan Wang; Oluwarotimi Folorunso; Pietro Scaduto; Syed R Ali; Fernanda Laezza; Jia Zhou
Journal:  Bioorg Med Chem Lett       Date:  2018-12-15       Impact factor: 2.823

4.  Qualitative prediction of blood-brain barrier permeability on a large and refined dataset.

Authors:  Markus Muehlbacher; Gudrun M Spitzer; Klaus R Liedl; Johannes Kornhuber
Journal:  J Comput Aided Mol Des       Date:  2011-11-23       Impact factor: 3.686

5.  Vascular permeability in the RG2 glioma model can be mediated by macropinocytosis and be independent of the opening of the tight junction.

Authors:  Karin Pernet-Gallay; Pierre-Henri Jouneau; Anne Bertrand; Julie Delaroche; Régine Farion; Chantal Rémy; Emmanuel L Barbier
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

6.  Synthesis and antitumoral activity of novel analogues monastrol-fatty acids against glioma cells.

Authors:  Franciele S De Oliveira; Patrick M De Oliveira; Luana M Farias; Rafael C Brinkerhoff; Rui Carlos M A Sobrinho; Tamara M Treptow; Caroline R Montes D'Oca; Marcelo A G Marinho; Mariana A Hort; Ana P Horn; Dennis Russowsky; Marcelo G Montes D'Oca
Journal:  Medchemcomm       Date:  2018-05-30       Impact factor: 3.597

7.  Isoquinoline Kelch-like ECH-Associated Protein 1-Nuclear Factor (Erythroid-Derived 2)-like 2 (KEAP1-NRF2) Inhibitors with High Metabolic Stability.

Authors:  Phillip R Lazzara; Brian P David; Aparna Ankireddy; Benjamin G Richardson; Katherine Dye; Kiira M Ratia; Sekhar P Reddy; Terry W Moore
Journal:  J Med Chem       Date:  2019-11-14       Impact factor: 7.446

8.  Evaluation of physicochemical properties and intestinal permeability of six dietary polyphenols in human intestinal colon adenocarcinoma Caco-2 cells.

Authors:  Himanshu Rastogi; Snehasis Jana
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-10-29       Impact factor: 2.441

9.  Anticancer potential of aminomethylidene-diazinanes I. Synthesis of arylaminomethylidene of diazinetriones and its cytotoxic effects tested in glioblastoma cells.

Authors:  Nichole A Pianovich; Mathew Dean; Adam Lassak; Krzysztof Reiss; Branko S Jursic
Journal:  Bioorg Med Chem       Date:  2017-08-12       Impact factor: 3.641

10.  Discovery of Dihydropyrrolo[1,2-a]pyrazin-3(4H)-one-Based Second-Generation GluN2C- and GluN2D-Selective Positive Allosteric Modulators (PAMs) of the N-Methyl-d-Aspartate (NMDA) Receptor.

Authors:  Matthew P Epplin; Ayush Mohan; Lynnea D Harris; Zongjian Zhu; Katie L Strong; John Bacsa; Phuong Le; David S Menaldino; Stephen F Traynelis; Dennis C Liotta
Journal:  J Med Chem       Date:  2020-07-06       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.